CN1594265A - Preparation method of gluconic acid and its salt - Google Patents
Preparation method of gluconic acid and its salt Download PDFInfo
- Publication number
- CN1594265A CN1594265A CN 200410040205 CN200410040205A CN1594265A CN 1594265 A CN1594265 A CN 1594265A CN 200410040205 CN200410040205 CN 200410040205 CN 200410040205 A CN200410040205 A CN 200410040205A CN 1594265 A CN1594265 A CN 1594265A
- Authority
- CN
- China
- Prior art keywords
- gluconate
- preparation
- gluconic acid
- solution
- gained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 title claims abstract description 32
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 title claims abstract description 30
- 239000000174 gluconic acid Substances 0.000 title claims abstract description 30
- 235000012208 gluconic acid Nutrition 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 150000003839 salts Chemical class 0.000 title abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 27
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 25
- 239000008103 glucose Substances 0.000 claims abstract description 25
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims abstract description 13
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940050410 gluconate Drugs 0.000 claims abstract description 13
- 229960001763 zinc sulfate Drugs 0.000 claims abstract description 6
- 229910000368 zinc sulfate Inorganic materials 0.000 claims abstract description 6
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims abstract description 5
- 239000011790 ferrous sulphate Substances 0.000 claims abstract description 4
- 235000003891 ferrous sulphate Nutrition 0.000 claims abstract description 4
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 43
- 239000010931 gold Substances 0.000 claims description 37
- 239000007864 aqueous solution Substances 0.000 claims description 22
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 20
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 18
- 229910052737 gold Inorganic materials 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- 238000000967 suction filtration Methods 0.000 claims description 2
- NEEHYRZPVYRGPP-IYEMJOQQSA-L calcium gluconate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O NEEHYRZPVYRGPP-IYEMJOQQSA-L 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 238000002156 mixing Methods 0.000 claims 2
- 239000012141 concentrate Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 33
- 239000003054 catalyst Substances 0.000 abstract description 22
- 239000004227 calcium gluconate Substances 0.000 abstract description 18
- 235000013927 calcium gluconate Nutrition 0.000 abstract description 18
- 229960004494 calcium gluconate Drugs 0.000 abstract description 18
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 abstract description 18
- 238000007254 oxidation reaction Methods 0.000 abstract description 13
- 230000003647 oxidation Effects 0.000 abstract description 11
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 230000003197 catalytic effect Effects 0.000 abstract description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 8
- 239000011777 magnesium Substances 0.000 abstract description 8
- 239000007791 liquid phase Substances 0.000 abstract description 7
- 230000008569 process Effects 0.000 abstract description 7
- 239000000920 calcium hydroxide Substances 0.000 abstract description 4
- 235000011116 calcium hydroxide Nutrition 0.000 abstract description 4
- 239000011701 zinc Substances 0.000 abstract description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 abstract description 3
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 abstract 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 abstract 1
- 235000001055 magnesium Nutrition 0.000 abstract 1
- 235000016804 zinc Nutrition 0.000 abstract 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 13
- 239000002245 particle Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 239000011575 calcium Substances 0.000 description 11
- 229940091250 magnesium supplement Drugs 0.000 description 10
- 239000011670 zinc gluconate Substances 0.000 description 10
- 235000011478 zinc gluconate Nutrition 0.000 description 10
- 229960000306 zinc gluconate Drugs 0.000 description 10
- 229910052749 magnesium Inorganic materials 0.000 description 9
- 239000001755 magnesium gluconate Substances 0.000 description 9
- 229960003035 magnesium gluconate Drugs 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 8
- 235000015778 magnesium gluconate Nutrition 0.000 description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical group [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 8
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 5
- 239000004222 ferrous gluconate Substances 0.000 description 5
- 235000013924 ferrous gluconate Nutrition 0.000 description 5
- 229960001645 ferrous gluconate Drugs 0.000 description 5
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 229960005069 calcium Drugs 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000176 sodium gluconate Substances 0.000 description 4
- 235000012207 sodium gluconate Nutrition 0.000 description 4
- 229940005574 sodium gluconate Drugs 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229910003771 Gold(I) chloride Inorganic materials 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010022971 Iron Deficiencies Diseases 0.000 description 2
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 239000003957 anion exchange resin Substances 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 229940023913 cation exchange resins Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000000498 cooling water Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009713 electroplating Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 2
- ZBKIUFWVEIBQRT-UHFFFAOYSA-N gold(1+) Chemical compound [Au+] ZBKIUFWVEIBQRT-UHFFFAOYSA-N 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001482237 Pica Species 0.000 description 1
- 101000650578 Salmonella phage P22 Regulatory protein C3 Proteins 0.000 description 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 101001040920 Triticum aestivum Alpha-amylase inhibitor 0.28 Proteins 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- GXUARMXARIJAFV-UHFFFAOYSA-L barium oxalate Chemical compound [Ba+2].[O-]C(=O)C([O-])=O GXUARMXARIJAFV-UHFFFAOYSA-L 0.000 description 1
- 229940094800 barium oxalate Drugs 0.000 description 1
- 239000010953 base metal Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052745 lead Inorganic materials 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及葡萄糖酸及其盐类的制备方法。采用Au/C催化剂液相催化氧化葡萄糖经氢氧化钙中和合成葡萄糖酸钙。以此为基础,经镁、锌、亚铁硫酸盐的置换反应获得相应葡萄糖酸盐,经硫酸置换反应获得葡萄糖酸。本发明用于生产葡萄糖酸及其盐类具有生产成本低廉、生产效率高、工艺流程简便的特点。The invention relates to a preparation method of gluconic acid and its salts. Calcium gluconate was synthesized by liquid-phase catalytic oxidation of glucose with Au/C catalyst and neutralized by calcium hydroxide. On this basis, the corresponding gluconate is obtained through the replacement reaction of magnesium, zinc and ferrous sulfate, and gluconic acid is obtained through the replacement reaction of sulfuric acid. The invention is used to produce gluconic acid and its salts and has the characteristics of low production cost, high production efficiency and simple process flow.
Description
技术领域technical field
本发明涉及葡萄糖酸及其盐类制备方法,特别是葡萄糖酸和其钙盐、镁盐、锌盐、亚铁盐等的制备方法。The invention relates to a preparation method of gluconic acid and its salts, in particular to a preparation method of gluconic acid and its calcium salt, magnesium salt, zinc salt, ferrous salt and the like.
背景技术Background technique
葡萄糖酸和其盐类是具有多种用途的重要有机化学产品。它们能用作食品添加剂和营养增补剂,络合剂,玻璃、钢铁表面的清洁剂,洗涤助剂等,广泛应用于食品、医药、电镀、建筑、纺织、和日用化工等领域。例如:(1)葡萄糖酸钙为钙制剂,临床主要用于补钙,治疗各种因缺钙引起的各种疾患。能促进骨骼和牙齿的钙化,维持神经肌肉正常兴奋性,降低毛细血管通透性,增加毛细血管壁的收缩性;防治钙缺乏症如手足抽搐症、骨发育不全、佝偻病及结核病、妊娠和哺乳期妇女的钙盐补充。(2)葡萄糖酸锌在人体内能解离成锌离子和葡萄糖酸,它们参与核糖核酸和脱氧核糖核酸的合成,可促进创口愈合,生长发育和体内含锌酶发挥正常功能。用于治疗缺锌引起的儿童生长发育迟缓、营养不良、厌食、异食癖、口腔溃疡、痤疮等疾病。(3)葡萄糖酸镁是近几年来被开发的葡萄糖酸盐类产品中的一种新型的补镁剂,镁是人体必需的常量元素,具有重要的生理功能,如镁与磷构成骨盐;镁是体内磷酸化和一些酶系统不可缺少的激活剂。临床上长期用硫酸镁作补镁剂,具有副作用小、生物利用度高和吸收率好等优点,是一种良好的补镁剂。但作为一种无机化合物,正逐步被新型补镁剂——葡萄糖酸镁所取代。补镁剂——葡萄糖酸的标准见美国F.C.CIII。(4)葡萄糖酸亚铁是良好的补铁剂,用于治疗缺铁性贫血。因为铁是血红蛋白的重要组成部分和氧化还原反应酶的活化剂。缺铁会引起缺铁性贫血症。尤以儿童缺铁导致贫血者较多。(5)葡萄糖酸钠具有优良的螯合性能,在金属防腐、水质阻垢、金属表面处理、电镀等方面已有广泛的用途。尤其作为石油、化工企业循环冷却水系统和低压锅炉、内燃机冷却水系统的水处理药剂每年用量很大。Gluconic acid and its salts are important organic chemical products with multiple uses. They can be used as food additives and nutritional supplements, complexing agents, cleaning agents for glass and steel surfaces, washing aids, etc., and are widely used in the fields of food, medicine, electroplating, construction, textiles, and daily chemicals. For example: (1) Calcium gluconate is a calcium preparation, which is mainly used clinically for calcium supplementation and treatment of various diseases caused by calcium deficiency. It can promote the calcification of bones and teeth, maintain the normal excitability of neuromuscular, reduce capillary permeability, increase the contractility of capillary wall; prevent calcium deficiency such as tetany, bone hypoplasia, rickets and tuberculosis, pregnancy and breastfeeding Calcium salt supplementation for period women. (2) Zinc gluconate can dissociate into zinc ions and gluconic acid in the human body. They participate in the synthesis of ribonucleic acid and deoxyribonucleic acid, which can promote wound healing, growth and development, and the normal function of zinc-containing enzymes in the body. It is used to treat children's growth retardation, malnutrition, anorexia, pica, oral ulcers, acne and other diseases caused by zinc deficiency. (3) Magnesium gluconate is a new type of magnesium supplement in gluconate products developed in recent years. Magnesium is an essential macroelement for the human body and has important physiological functions. For example, magnesium and phosphorus form bone salt; Magnesium is an indispensable activator of phosphorylation and some enzyme systems in the body. Magnesium sulfate has been used clinically as a magnesium supplement for a long time. It has the advantages of small side effects, high bioavailability and good absorption rate, and is a good magnesium supplement. However, as an inorganic compound, it is gradually being replaced by a new type of magnesium supplement—magnesium gluconate. Magnesium supplements—see the standard of gluconic acid in the United States F.C.CIII. (4) Ferrous gluconate is a good iron supplement for the treatment of iron deficiency anemia. Because iron is an important component of hemoglobin and an activator of redox enzymes. Iron deficiency can cause iron deficiency anemia. Especially children with iron deficiency lead to anemia more. (5) Sodium gluconate has excellent chelating properties, and has been widely used in metal anticorrosion, water scale inhibition, metal surface treatment, electroplating, etc. Especially as a water treatment agent for circulating cooling water systems of petroleum and chemical enterprises, low-pressure boilers, and internal combustion engine cooling water systems, the annual consumption is very large.
目前,国内外工业化生产葡萄糖酸及其盐类的主要方法有:生物发酵法:采用细菌或氧化酶将葡萄糖氧化成葡萄糖酸。该法发酵时间长,产品色泽不易控制,转化率低,对生产环境无菌化程度要求高。At present, the main methods of industrial production of gluconic acid and its salts at home and abroad are: biological fermentation method: using bacteria or oxidase to oxidize glucose into gluconic acid. This method takes a long time to ferment, the color of the product is difficult to control, the conversion rate is low, and the requirements for the aseptic degree of the production environment are high.
均相化学氧化法:主要是指次氯酸钠氧化法和过氧化氢氧化法,该方法副产物多,产物难分离,产率低。Homogeneous chemical oxidation method: mainly refers to sodium hypochlorite oxidation method and hydrogen peroxide oxidation method. This method has many by-products, difficult separation of products, and low yield.
电解氧化法:该方法是在电解槽中加入一定浓度的葡萄糖溶液和适宜的电解质,在一定温度和电流密度下恒电流电解。该方法在工业生产中能耗大,条件不易控制。Electrolytic oxidation method: This method is to add a certain concentration of glucose solution and a suitable electrolyte in the electrolytic cell, and conduct constant current electrolysis at a certain temperature and current density. This method consumes a lot of energy in industrial production, and the conditions are not easy to control.
多相催化氧化法:该方法具有工艺过程简单,反应条件温和(各种气-液-固三相混合的反应器在常压下均可采用,反应温度一般控制在60℃以下),反应时间短,转化率高,三废少,产物易于处理等优点。其催化剂一般使用铂族金属催化剂,例如,公告了使用Pt/C、Pd/C等催化剂催化氧化葡萄糖的专利(GB 1208101,JP8007230,JP 7652121,JP5872538)。此外,也有用Bi、Pb等贱金属对Pt/C或Pd/C进行改性应用于这一催化氧化反应的专利(US Patent 5132452,US Patent 4843173,DE-OS2936652)。但多相催化氧化法中使用的Pt/C或Pd/C催化剂的贵金属耗量较大,导致生产成本过高,且Pt/C或Pd/C催化剂的氧化选择性较差容易中毒,其失效催化剂中贵金属难于回收。Heterogeneous catalytic oxidation method: This method has the advantages of simple process, mild reaction conditions (various gas-liquid-solid three-phase mixed reactors can be used under normal pressure, and the reaction temperature is generally controlled below 60°C), and the reaction time Short, high conversion rate, less waste, easy to handle the product and so on. The catalyst generally uses a platinum group metal catalyst, for example, a patent (GB 1208101, JP8007230, JP 7652121, JP5872538) for catalytic oxidation of glucose using catalysts such as Pt/C and Pd/C has been announced. In addition, there are also patents for modifying Pt/C or Pd/C with base metals such as Bi and Pb and applying them to this catalytic oxidation reaction (US Patent 5132452, US Patent 4843173, DE-OS2936652). However, the noble metal consumption of the Pt/C or Pd/C catalyst used in the heterogeneous catalytic oxidation method is large, resulting in high production costs, and the oxidation selectivity of the Pt/C or Pd/C catalyst is poor and easy to be poisoned, and its failure The precious metals in the catalyst are difficult to recover.
发明内容Contents of the invention
本发明目的一是提供一种简便的钙、镁、锌、亚铁等的葡萄糖酸盐制备方法。Purpose one of the present invention is to provide a kind of easy and convenient method for preparing gluconate of calcium, magnesium, zinc, ferrous etc.
本发明目的二是提供一种简便的葡萄糖酸制备方法The second object of the present invention is to provide a kind of easy gluconic acid preparation method
采用下列顺序工艺技术实现上述发明目的一:Adopt following sequential technology to realize above-mentioned invention object one:
①将载有金颗粒的粉末状活性炭即Au/C催化剂与葡萄糖水溶液混合,保持所得混合溶液的温度为40℃~55℃;① Mix the powdery activated carbon loaded with gold particles, that is, the Au/C catalyst, with the aqueous glucose solution, and keep the temperature of the resulting mixed solution at 40°C to 55°C;
②向步骤①所得混合物通入40~1000毫升/分钟氧气或空气,搅拌下加入Ca(OH)2水溶液;2. Pass 40~1000 milliliters/minute oxygen or air into step 1. gained mixture, add Ca(OH) 2 aqueous solution under stirring;
③抽滤、浓缩、结晶、风干等传统工艺手段处理步骤②所得溶液获得相应葡萄糖酸盐。③Traditional process means such as suction filtration, concentration, crystallization, air-drying, etc. to process step ②The obtained solution obtains the corresponding gluconate.
选择步骤①中金颗粒的粒度为5~15nm,活性炭的比表面积800~1500m2/g,活性炭的粒度100~400目,金颗粒∶活性炭质量比=0.5~3∶100。In the selection step ①, the particle size of gold particles is 5-15nm, the specific surface area of activated carbon is 800-1500m 2 /g, the particle size of activated carbon is 100-400 mesh, and the mass ratio of gold particles: activated carbon is 0.5-3:100.
选择步骤①中葡萄糖水溶液的百分比重量浓度1~20%,金颗粒∶葡萄糖质量比=1∶500~3000。In the selection step ①, the percentage weight concentration of the glucose aqueous solution is 1-20%, and the gold particle: glucose mass ratio is 1:500-3000.
步骤②所得溶液的pH值优选为8~9。The pH value of the solution obtained in step ② is preferably 8-9.
向步骤②所得溶液中加入硫酸盐,即可获得其它相应盐类。Add sulfate to the solution obtained in step ② to obtain other corresponding salts.
上述硫酸盐可以是硫酸锌、硫酸镁或硫酸亚铁之任一种。Above-mentioned sulfate can be any one of zinc sulfate, magnesium sulfate or ferrous sulfate.
优选硫酸盐∶步骤②所得溶液中含有的葡萄糖酸钙摩尔比=1∶1。Preferred sulfate: the molar ratio of calcium gluconate contained in the solution obtained in step ② is 1:1.
上述发明目的二的葡萄糖酸制备方法,依次包括下列工艺步骤:The preparation method of gluconic acid of the above-mentioned invention object two, comprises the following processing steps successively:
①将载有金颗粒的粉末状活性炭与葡萄糖水溶液混合,保持所得混合溶液的温度为40℃~55℃;① Mix the powdered activated carbon loaded with gold particles and the aqueous glucose solution, and keep the temperature of the resulting mixed solution at 40°C to 55°C;
②向步骤①所得混合物通入400~1000毫升/分钟氧气或空气,搅拌下加入Ca(OH)2水溶液;2. Pass 400~1000 milliliters/minute oxygen or air into step 1. gained mixture, add Ca(OH) 2 aqueous solution under stirring;
③向步骤②所得混合物中加入硫酸,60℃~90℃水浴加热1~3小时,经后续传统工艺处理得到葡萄糖酸溶液。③ Add sulfuric acid to the mixture obtained in step ②, heat in a water bath at 60° C. to 90° C. for 1 to 3 hours, and obtain a gluconic acid solution through subsequent conventional processing.
对技术方案二的工艺参数,可以作出如下择优调整:For the process parameters of technical scheme two, the following optimal adjustments can be made:
优选步骤①金颗粒的粒度为5~15nm,活性炭的比表面积800~1500m2/g,活性炭的粒度100~400目,金颗粒∶所述活性炭质量比=0.5~3∶100,金颗粒∶葡萄糖质量比=1∶500~3000,步骤②所得溶液的pH值为8~9。Preferred step 1. The particle size of the gold particles is 5-15nm, the specific surface area of the activated carbon is 800-1500m2 /g, the particle size of the activated carbon is 100-400 mesh, the mass ratio of gold particles: the activated carbon=0.5-3:100, gold particles: glucose Mass ratio=1:500~3000, the pH value of the solution obtained in step ② is 8~9.
优选步骤③中硫酸∶步骤②所得溶液中含有的葡萄糖酸钙摩尔比=1∶1。Preferred step 3. sulfuric acid: step 2. calcium gluconate mol ratio contained in the solution gained=1:1.
上述两个技术方案中使用的Au/C催化剂采用如下顺序工艺技术制备:The Au/C catalyst used in the above two technical schemes is prepared by the following sequential process technology:
(一)用波长为254纳米或300纳米之一,总辐射强度0.5~1卡/米2·秒的紫外光,照射含有HAuCl4或AuCl3之任一种的分子量为400、600、1000之任一种的聚乙二醇与丙酮的混合水溶液15~25分钟,获得金胶体溶液。其中,HAuCl4或AuCl3中的Au(III)离子∶聚乙二醇∶丙酮摩尔比=4.88×10-4∶11.28×10-2∶1。(1) Use ultraviolet light with a wavelength of 254 nanometers or 300 nanometers and a total radiation intensity of 0.5 to 1 cal/m 2 sec to irradiate any one of HAuCl 4 or AuCl 3 with a molecular weight of 400, 600, or 1000 Any mixed aqueous solution of polyethylene glycol and acetone for 15 to 25 minutes to obtain a gold colloidal solution. Wherein, the molar ratio of Au(III) ions in HAuCl 4 or AuCl 3 : polyethylene glycol: acetone = 4.88×10 -4 : 11.28×10 -2 :1.
(二)搅拌条件下,将活性炭浸入步骤(一)所得金胶体溶液中。(2) Under stirring conditions, the activated carbon is immersed in the gold colloidal solution obtained in step (1).
上述技术方案一中,使用过饱和的Ca(OH)2水溶液,即石灰乳水溶液,有利于加快反应进程。此外,利用与上述葡萄糖酸钙制备工艺相同的流程,可以得到葡萄糖酸钠。In above-mentioned technical scheme one, use supersaturated Ca (OH) Aqueous solution, i.e. aqueous lime milk solution, helps to accelerate reaction process. In addition, sodium gluconate can be obtained by using the same process as the above calcium gluconate preparation process.
本发明利用Au/C催化剂,一步法液相催化氧化葡萄糖合成葡萄糖酸钙,并由此制备葡萄糖酸以及其它盐类,例如葡萄糖酸锌、葡萄糖酸镁、葡萄糖酸亚铁等。与目前工业化生产上多采用的生物发酵法和使用Pt/C、Pd/C等催化剂的多相催化氧化法相比,本发明的Au/C催化剂的葡萄糖液相催化氧化反应具有如下特点:(1)催化剂中的Au含量是Pt/C、Pd/C等催化剂中的Pt或Pd含量的1/3~1/5,钙试剂原料便宜,因而能降低本发明的生产成本。(2)Au/C催化剂具有更高的催化活性和氧化选择性,且不易中毒,催化寿命较长,有利于提高本发明的生产效率。(3)金是生物相容的元素,生产过程中痕量或超痕量的金流失到产品中,用于食品或医药,对人体不会产生危害,反而会产生好的影响(Haruta M.Gold Bulletin,2001,34卷,40页)。(4)发明的工艺流程简便,无污染。The invention utilizes Au/C catalyst to catalyze and oxidize glucose in one-step liquid phase to synthesize calcium gluconate, and thereby prepare gluconic acid and other salts, such as zinc gluconate, magnesium gluconate, ferrous gluconate and the like. Compared with the biofermentation method and the heterogeneous catalytic oxidation method using catalyzers such as Pt/C and Pd/C, the glucose liquid-phase catalytic oxidation reaction of the Au/C catalyst of the present invention has the following characteristics: (1) ) The Au content in the catalyst is 1/3~1/5 of the Pt or Pd content in catalysts such as Pt/C, Pd/C, and the calcium reagent raw material is cheap, thereby can reduce the production cost of the present invention. (2) The Au/C catalyst has higher catalytic activity and oxidation selectivity, is less likely to be poisoned, and has a longer catalytic life, which is conducive to improving the production efficiency of the present invention. (3) Gold is a biocompatible element. During the production process, trace or ultra-trace amounts of gold are lost into the product and used for food or medicine, which will not cause harm to the human body, but will have a good effect (Haruta M. Gold Bulletin, 2001, Vol. 34, p. 40). (4) The technical process of the invention is simple and convenient, and has no pollution.
以硫酸锌为例,本发明葡萄糖酸钙与镁、锌、亚铁的硫酸盐的反应式如下:Taking zinc sulfate as example, the reaction formula of calcium gluconate of the present invention and magnesium, zinc, ferrous sulfate is as follows:
此外,通过本发明获得葡萄糖酸之后,也可以此作为中间体,获得镁、锌、亚铁的葡萄糖酸盐。In addition, after gluconic acid is obtained by the present invention, it can also be used as an intermediate to obtain magnesium, zinc, and ferrous gluconate.
本发明所采用的试剂纯度均为分析纯市售产品。The purity of the reagents used in the present invention are commercially available products of analytical grade.
具体实施方式Detailed ways
实施例1:Example 1:
制备葡萄糖酸钙Preparation of Calcium Gluconate
在液相反应容器中,按葡萄糖与Au/C催化剂中Au的质量比为500∶1,将葡萄糖水溶液和Au/C催化剂混合,葡萄糖水溶液重量百分比浓度为1%,反应体系的温度为40℃,通入400ml/min氧气,在不断搅拌下加入石灰乳(Ca(OH)2)水溶液,使反应溶液pH值维持在8,直到反应溶液的pH值保持20min不变为止,此时反应结束。然后将溶液抽滤、减压浓缩、结晶、风干等工序处理,即得产品葡萄糖酸钙。In the liquid phase reaction vessel, according to the mass ratio of glucose and Au in the Au/C catalyst is 500:1, the glucose aqueous solution and the Au/C catalyst are mixed, the concentration of the glucose aqueous solution is 1% by weight, and the temperature of the reaction system is 40°C , feed 400ml/min oxygen, add milk of lime (Ca(OH) 2 ) aqueous solution under constant stirring, keep the pH value of the reaction solution at 8, until the pH value of the reaction solution remains unchanged for 20min, and the reaction ends at this time. Then the solution is filtered by suction, concentrated under reduced pressure, crystallized, and air-dried to obtain the product calcium gluconate.
实施例2:Example 2:
制备葡萄糖酸钙Preparation of Calcium Gluconate
在液相反应容器中,按葡萄糖与Au/C催化剂中Au的质量比为1500∶1,将葡萄糖水溶液和Au/C催化剂混合,葡萄糖水溶液重量百分比浓度为10%,反应体系的温度为45℃,通入600ml/min氧气,在不断搅拌下加入石灰乳(Ca(OH)2)水溶液,使反应溶液pH值维持在8.5,直到反应溶液的pH值保持20min不变为止,此时反应结束。然后将溶液抽滤、减压浓缩、结晶、风干等工序处理,即得产品葡萄糖酸钙。In the liquid phase reaction vessel, the mass ratio of glucose and Au in the Au/C catalyst is 1500:1, the glucose aqueous solution and the Au/C catalyst are mixed, the concentration of the glucose aqueous solution is 10% by weight, and the temperature of the reaction system is 45°C , feed 600ml/min oxygen, add milk of lime (Ca(OH) 2 ) aqueous solution under constant stirring, keep the pH value of the reaction solution at 8.5, until the pH value of the reaction solution remains unchanged for 20min, then the reaction ends. Then the solution is filtered by suction, concentrated under reduced pressure, crystallized, and air-dried to obtain the product calcium gluconate.
实施例3:Example 3:
制备葡萄糖酸钙Preparation of Calcium Gluconate
在液相反应容器中,按葡萄糖与Au/C催化剂中Au的质量比为3000∶1,将葡萄糖水溶液和Au/C催化剂混合,葡萄糖水溶液重量百分比浓度为20%,反应体系的温度为55℃,通入1000ml/min空气,在不断搅拌下加入石灰乳(Ca(OH)2)水溶液,使反应溶液pH值维持在9,直到反应溶液的pH值保持20min不变为止,此时反应结束。然后将溶液抽滤、减压浓缩、结晶、风干等工序处理,即得产品葡萄糖酸钙。In the liquid phase reaction vessel, according to the mass ratio of glucose and Au in the Au/C catalyst is 3000:1, the glucose aqueous solution and the Au/C catalyst are mixed, the concentration of the glucose aqueous solution is 20% by weight, and the temperature of the reaction system is 55°C , feed 1000ml/min air, add milk of lime (Ca(OH) 2 ) aqueous solution under constant stirring, keep the pH value of the reaction solution at 9, until the pH value of the reaction solution remains unchanged for 20min, then the reaction ends. Then the solution is filtered by suction, concentrated under reduced pressure, crystallized, and air-dried to obtain the product calcium gluconate.
实施例4:Example 4:
制备葡萄糖酸锌、镁或亚铁等盐Preparation of salts such as zinc, magnesium or ferrous gluconate
以制备葡萄糖酸锌为例,将实施例1、2或3之任一制得的葡萄糖酸钙溶液,与硫酸锌溶液混合,葡萄糖酸钙∶硫酸锌摩尔比=1∶1,加热反应。反应结束后将硫酸钙沉淀趁热滤出,然后将滤液经过减压浓缩、结晶、风干等工序处理,即获得葡萄糖酸锌。Taking the preparation of zinc gluconate as an example, the calcium gluconate solution prepared in any one of Examples 1, 2 or 3 is mixed with the zinc sulfate solution, calcium gluconate: zinc sulfate molar ratio=1:1, and heated for reaction. After the reaction is completed, the calcium sulfate precipitate is filtered out while it is hot, and then the filtrate is concentrated under reduced pressure, crystallized, and air-dried to obtain zinc gluconate.
葡萄糖酸镁和葡萄糖酸亚铁等葡萄糖酸盐产品的制备与上述葡萄糖酸锌制备流程相同。The preparation of gluconate products such as magnesium gluconate and ferrous gluconate is the same as the above-mentioned zinc gluconate preparation process.
实施例5:Example 5:
制备葡萄糖酸production of gluconic acid
将实施例1获得的葡萄糖酸钙0.5mol调成水溶液,置于适宜的反应容器中,搅拌下缓慢加入0.5mol浓硫酸,并于60℃水浴中加热反应1.5h。趁热滤去析出的硫酸钙沉淀,滤液冷却后,以适宜的流速流过阴、阳离子交换树脂的交换柱,得到高纯度的葡萄糖酸溶液。Adjust 0.5 mol of calcium gluconate obtained in Example 1 into an aqueous solution, place it in a suitable reaction vessel, slowly add 0.5 mol of concentrated sulfuric acid under stirring, and heat and react in a water bath at 60° C. for 1.5 h. Filtrate the precipitated calcium sulfate precipitate while it is hot. After the filtrate is cooled, it flows through the exchange column of anion and cation exchange resins at an appropriate flow rate to obtain a high-purity gluconic acid solution.
实施例6:Embodiment 6:
制备葡萄糖酸production of gluconic acid
将实施例2制得的葡萄糖酸钙1mol调成水溶液,置于在适宜的反应容器中,搅拌下缓慢加入1mol浓硫酸,并于80℃水浴中加热反应1h。趁热滤去析出的硫酸钙沉淀,滤液冷却,所得到的葡萄糖酸用氢氧化钡和草酸为沉淀剂进行纯化,除去少量的SO4 2-和Ca2+,过多的Ba2+与草酸生成草酸钡沉淀被除去,得到高纯度的葡萄糖酸溶液。Adjust 1 mol of calcium gluconate prepared in Example 2 into an aqueous solution, place it in a suitable reaction vessel, slowly add 1 mol of concentrated sulfuric acid under stirring, and heat and react in a water bath at 80°C for 1 h. Filter the precipitated calcium sulfate precipitate while it is hot, cool the filtrate, and purify the obtained gluconic acid with barium hydroxide and oxalic acid as precipitants to remove a small amount of SO 4 2- and Ca 2+ , and excess Ba 2+ and oxalic acid The resulting barium oxalate precipitate was removed to obtain a high-purity gluconic acid solution.
实施例7:Embodiment 7:
制备葡萄糖酸production of gluconic acid
将实施例3获得的葡萄糖酸钙1.5mol调成水溶液,置于适宜的反应容器中,搅拌下缓慢加入1.5mol浓硫酸,并于90℃水浴中加热反应3h。趁热滤去析出的硫酸钙沉淀,滤液冷却后,以适宜的流速流过阴、阳离子交换树脂的交换柱,得到高纯度的葡萄糖酸溶液。Adjust 1.5 mol of calcium gluconate obtained in Example 3 into an aqueous solution, place it in a suitable reaction vessel, slowly add 1.5 mol of concentrated sulfuric acid under stirring, and heat and react in a water bath at 90° C. for 3 hours. Filtrate the precipitated calcium sulfate precipitate while it is hot. After the filtrate is cooled, it flows through the exchange column of anion and cation exchange resins at an appropriate flow rate to obtain a high-purity gluconic acid solution.
实施例8:Embodiment 8:
以葡萄糖酸为中间体制备锌、镁的葡萄糖酸盐Preparation of Zinc and Magnesium Gluconate Using Gluconic Acid as Intermediate
葡萄糖酸锌:将实施例5获得的葡萄糖酸溶液调节至浓度0.1mol/L,于60℃水浴中搅拌下分批加入0.05mol氧化锌固体粉末,调节pH小于6,反应5h,至溶液呈透明状态。过滤,滤液减压浓缩至约原体积的1/3。加入10ml无水乙醇,放置约8小时使其充分结晶。真空干燥得白色结晶状葡萄糖酸锌粉末。Zinc gluconate: adjust the gluconic acid solution obtained in Example 5 to a concentration of 0.1mol/L, add 0.05mol zinc oxide solid powder in batches under stirring in a water bath at 60°C, adjust the pH to less than 6, and react for 5 hours until the solution becomes transparent state. After filtration, the filtrate was concentrated under reduced pressure to about 1/3 of the original volume. Add 10ml of absolute ethanol and let it stand for about 8 hours to fully crystallize. Vacuum dried to obtain white crystalline zinc gluconate powder.
葡萄糖酸镁:实施例6获得的葡萄糖酸溶液调节到浓度0.1mol/L,于65℃水浴中搅拌下分批加入0.05mol氧化镁固体粉末,调节pH小于6,反应2h,至溶液呈透明状态。过滤,滤液减压浓缩至约原体积的1/3。加入10ml无水乙醇,放置9h使其充分结晶。真空干燥得白色结晶状葡萄糖酸镁粉末。Magnesium gluconate: adjust the gluconic acid solution obtained in Example 6 to a concentration of 0.1mol/L, add 0.05mol magnesium oxide solid powder in batches under stirring in a water bath at 65°C, adjust the pH to less than 6, and react for 2 hours until the solution is transparent . After filtration, the filtrate was concentrated under reduced pressure to about 1/3 of the original volume. Add 10ml of absolute ethanol and let it stand for 9h to fully crystallize. Vacuum dried to obtain white crystalline magnesium gluconate powder.
实施例9:Embodiment 9:
制备葡萄糖酸钠Preparation of sodium gluconate
在液相反应容器中,按葡萄糖与Au/C催化剂中Au的质量比为2000∶1,将葡萄糖水溶液和Au/C催化剂混合,葡萄糖水溶液重量百分比浓度为5%,反应体系的温度为50℃,通入800ml/min空气,在不断搅拌下加入Na(OH)水溶液,使反应溶液pH值维持在8,直到反应溶液的pH值保持10min不变为止,此时反应结束。然后将溶液抽滤、减压浓缩、结晶、风干等工序处理,即得产品葡萄糖酸钠。In the liquid phase reaction vessel, the mass ratio of glucose and Au in the Au/C catalyst is 2000:1, the glucose aqueous solution and the Au/C catalyst are mixed, the concentration of the glucose aqueous solution is 5% by weight, and the temperature of the reaction system is 50°C , feed 800ml/min air, add Na(OH) aqueous solution under constant stirring, make the pH value of the reaction solution maintain at 8, until the pH value of the reaction solution remains unchanged for 10min, the reaction ends at this time. Then the solution is filtered by suction, concentrated under reduced pressure, crystallized, and air-dried to obtain the product sodium gluconate.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100402059A CN1319930C (en) | 2004-07-11 | 2004-07-11 | Preparation method of gluconic acid and its salt |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100402059A CN1319930C (en) | 2004-07-11 | 2004-07-11 | Preparation method of gluconic acid and its salt |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1594265A true CN1594265A (en) | 2005-03-16 |
CN1319930C CN1319930C (en) | 2007-06-06 |
Family
ID=34664532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100402059A Expired - Fee Related CN1319930C (en) | 2004-07-11 | 2004-07-11 | Preparation method of gluconic acid and its salt |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1319930C (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101209962B (en) * | 2006-12-28 | 2011-08-24 | 浙江山下湖珍珠集团股份有限公司 | Method for preparing calcium magnesium gluconate |
CN102190578A (en) * | 2011-03-09 | 2011-09-21 | 石允生 | Method for preparing hypophosphorous acid (salt) and gluconic acid (salt) from glucose phosphate serving as raw material |
CN101648862B (en) * | 2009-09-18 | 2012-08-22 | 郑州瑞普生物工程有限公司 | Production technology of zine gluconate |
CN102992998A (en) * | 2012-12-21 | 2013-03-27 | 江西新赣江药业有限公司 | Preparation method of ferrous gluconate |
CN103483181A (en) * | 2013-08-30 | 2014-01-01 | 洪军 | Calcium zinc gluconate compound |
CN107899574A (en) * | 2017-11-01 | 2018-04-13 | 红河学院 | Au Pd/C method for preparing catalyst and its application |
CN109482224A (en) * | 2018-11-26 | 2019-03-19 | 华南理工大学 | The doped meso-porous carbon nanocatalyst of iridium dioxide composite nitrogen and its method of preparation and catalytic oxidation of glucose synthesis of glucose acid |
CN110105209A (en) * | 2019-05-22 | 2019-08-09 | 广东信诚达科技有限公司 | δ-fatty acyl gluconate and preparation method thereof and PVC heat stabilizer |
CN110256234A (en) * | 2019-07-02 | 2019-09-20 | 扬州中宝药业股份有限公司 | A kind of preparation method of calcium gluconate |
CN110776416A (en) * | 2019-11-08 | 2020-02-11 | 上海永通生态工程股份有限公司 | Preparation method of iron glucoheptonate |
CN112028948A (en) * | 2020-07-02 | 2020-12-04 | 浙江晟格生物科技有限公司 | Method for preparing lactobionic acid by using lactose as raw material |
CN117924076A (en) * | 2023-12-25 | 2024-04-26 | 北京斯利安药业有限公司 | Zinc gluconate dihydrate and preparation method thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101832997A (en) * | 2010-04-23 | 2010-09-15 | 中国科学院上海应用物理研究所 | Application of gold nanoparticles serving as glucose oxidase |
CN101832937A (en) * | 2010-04-23 | 2010-09-15 | 中国科学院上海应用物理研究所 | Method for detecting glucose based on nanometer materials |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1019819B (en) * | 1990-11-27 | 1992-12-30 | 凌源钢铁公司 | Method for manufacturing return ore core pellet |
-
2004
- 2004-07-11 CN CNB2004100402059A patent/CN1319930C/en not_active Expired - Fee Related
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101209962B (en) * | 2006-12-28 | 2011-08-24 | 浙江山下湖珍珠集团股份有限公司 | Method for preparing calcium magnesium gluconate |
CN101648862B (en) * | 2009-09-18 | 2012-08-22 | 郑州瑞普生物工程有限公司 | Production technology of zine gluconate |
CN102190578A (en) * | 2011-03-09 | 2011-09-21 | 石允生 | Method for preparing hypophosphorous acid (salt) and gluconic acid (salt) from glucose phosphate serving as raw material |
CN102190578B (en) * | 2011-03-09 | 2013-06-26 | 石允生 | Method for preparing hypophosphorous acid (salt) and gluconic acid (salt) from glucose phosphate serving as raw material |
CN102992998A (en) * | 2012-12-21 | 2013-03-27 | 江西新赣江药业有限公司 | Preparation method of ferrous gluconate |
CN102992998B (en) * | 2012-12-21 | 2015-10-28 | 江西新赣江药业有限公司 | A kind of preparation method of Ferrous Gluconate |
CN103483181A (en) * | 2013-08-30 | 2014-01-01 | 洪军 | Calcium zinc gluconate compound |
CN103483181B (en) * | 2013-08-30 | 2015-08-26 | 洪军 | A kind of Calcium zinc gluconate compound |
CN107899574A (en) * | 2017-11-01 | 2018-04-13 | 红河学院 | Au Pd/C method for preparing catalyst and its application |
CN109482224A (en) * | 2018-11-26 | 2019-03-19 | 华南理工大学 | The doped meso-porous carbon nanocatalyst of iridium dioxide composite nitrogen and its method of preparation and catalytic oxidation of glucose synthesis of glucose acid |
CN109482224B (en) * | 2018-11-26 | 2020-09-22 | 华南理工大学 | Iridium dioxide composite nitrogen-doped mesoporous carbon nano catalyst, preparation method thereof and method for synthesizing gluconic acid by catalytic oxidation of glucose |
CN110105209A (en) * | 2019-05-22 | 2019-08-09 | 广东信诚达科技有限公司 | δ-fatty acyl gluconate and preparation method thereof and PVC heat stabilizer |
CN110105209B (en) * | 2019-05-22 | 2022-04-08 | 广东信诚达科技有限公司 | Delta-fatty acyl gluconate and preparation method thereof, and PVC heat stabilizer |
CN110256234A (en) * | 2019-07-02 | 2019-09-20 | 扬州中宝药业股份有限公司 | A kind of preparation method of calcium gluconate |
CN110256234B (en) * | 2019-07-02 | 2021-08-13 | 扬州中宝药业股份有限公司 | Preparation method of calcium gluconate |
CN110776416A (en) * | 2019-11-08 | 2020-02-11 | 上海永通生态工程股份有限公司 | Preparation method of iron glucoheptonate |
CN112028948A (en) * | 2020-07-02 | 2020-12-04 | 浙江晟格生物科技有限公司 | Method for preparing lactobionic acid by using lactose as raw material |
CN117924076A (en) * | 2023-12-25 | 2024-04-26 | 北京斯利安药业有限公司 | Zinc gluconate dihydrate and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1319930C (en) | 2007-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1319930C (en) | Preparation method of gluconic acid and its salt | |
CN104450806B (en) | A kind of method that enzyme process prepares sodium gluconate | |
CN1304362C (en) | Prepn process of metal-amino acid chelate | |
CN103602710B (en) | Method of preparing calcium gluconate by composite immobilized enzyme | |
CN103962132B (en) | Activated carbon supported nano catalyst and methods for making and using same thereof | |
CN101486639A (en) | Novel method for synthesizing mixed glucose derivative | |
CN108383746A (en) | A kind of preparation method of glycine zine chelate | |
CN101249443A (en) | Catalyst for preparing sodium gluconate, preparation method and application thereof | |
CN103739479B (en) | Method for preparing sodium gluconate through catalytic oxidation of glucose by using gold catalyst | |
CN1629359A (en) | Method for preparing polyaluminum chloride by electrolysis with shape-stable anode | |
CN1055092C (en) | Preparation of gluconic acid by hydrogen peroxide oxidizing process | |
CN100516026C (en) | Preparation method of amino acid chelated calcium | |
CN1187091C (en) | Oral vanadium replenishing agent with bimetallic oxide as carrier and its prepn and usage | |
CN111663151B (en) | A process for preparing high-purity calcium glycinate by electrochemical-complexation reaction technology | |
CN1172683C (en) | Oral selenium supplement with double metal oxide as carrier and its preparation and use method | |
CN1009114B (en) | Lactic acid prodn. by fermentating and coagulating subsided separation | |
CN115888711B (en) | Sodium titanate nanowire supported copper catalyst and preparation method and application thereof | |
CN110116012A (en) | CeO2Optic catalytic composite material and preparation method thereof and Hospital Sewage Treatment method | |
CN1189098C (en) | Composite nutrient enriching substance with zinc, potassium and glutamic acid coordination compound | |
CN115155558B (en) | Solid solution carrier and preparation method of ruthenium-based catalyst | |
CN1698649A (en) | Oral zinc supplement with hydrotalcite as carrier and its preparation and application method | |
CN102614899A (en) | Synthesis method of load type silver chloride/silver catalyst | |
CN1775733A (en) | Calcium nervonate and its preparing method and use | |
CN1826943A (en) | Supplementing agent for controlled and slow-release sulfur, its preparation method and use | |
CN1122802A (en) | Method for preparing ascorbic acid by quantitative conversion of sodium colombate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070606 Termination date: 20130711 |